Repligen | RGEN - 股票



金融业
股票价格
USD
资产
USD 2.95B
现金及等价物
USD 606.78M
销售成本
USD 94.09M
流动资产
USD 1.2B
流动负债
USD 132.66M
债务
USD 690.94M
EBIT
USD 21.13M
EBITDA
USD 43.77M
员工
1.78K
EPS每股收益
USD 0.54
股本和储备
USD 2.11B
销售毛利
USD 110.04M
债务利息支出
USD 5.66M
利息收入
USD 7.31M
贷款资金
USD 551.05M
市值
USD 9.28B
净收入
USD 5.01M
营业费用
USD 183M
营业利润
USD 21.13M
普通股股本
USD 56.43M
PE价格收益
105.09
税前利润
USD 14.15M
销售收入
USD 204M
销售和管理费用
USD 76.62M
股票
USD 186.6M
贸易债权人
USD 33.23M
应收帐款人
USD 157.71M


股票 更改 日
Agilent USD 1.09B 30M 2026-03
Align Technology USD 212.24M 2.7M 2026-06
Bio Techne USD 195.74M 5.43M 2026-06
BioMarin Pharmaceutical USD 1.78B 509.3M 2026-06
Bristol-Myers Squibb USD 2.74B 19M 2026-06
Bruker USD 1.12B 1.4M 2026-06
Charles River Laboratories USD 346.26M 13.46M 2026-06
Danaher USD 3.26B 652M 2026-06
Dentsply International USD 665M 6M 2026-06
General Electric Aerospace USD 12.44B 73M 2026-06
Henry Schein USD 2.06B 45M 2026-06
Illumina USD 629M 18M 2026-06
Mettler Toledo International USD 411.56M 6.74M 2026-06
Myriad Genetics USD 30.6M 2.7M 2026-06
OraSure Technologies USD 30.07M 236K 2026-06
Pacific Biosciences Of California USD 61.08M 10.06M 2026-06
Pfizer USD 9.94B 722M 2026-06
Repligen USD 186.6M 7.35M 2026-06
Revvity USD 378.5M 9M 2026-06
Standard Biotools USD 18.59M 1.39M 2026-03
Thermo Fisher Scientific USD 5.5B 71M 2026-03
Waters USD 1.38B 119M 2026-06
West Pharmaceutical Services USD 447.4M 5.2M 2026-06